PatientsVille.com Logo

PatientsVille

Lonarid Side Effects

Common Lonarid Side Effects

The most commonly reported Lonarid side effects (click to view or check a box to report):

Condition Aggravated (1)
Diarrhoea (1)
Incision Site Haemorrhage (1)
Chronic Obstructive Pulmonary Disease (1)
Cardiac Arrest (1)
Toxic Epidermal Necrolysis (1)
Body Temperature Decreased (1)
Infarction (1)
Infection (1)
Suicide Attempt (1)
Tachycardia (1)
Thrombocytopenia (1)
Stevens-johnson Syndrome (1)
Post Procedural Vomiting (1)
Miosis (1)
Pleuritic Pain (1)
Amnesia (1)


If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Lonarid Side Effects Reported to FDA

The following Lonarid reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Lonarid on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Condition Aggravated, Infection, Chronic Obstructive Pulmonary Disease, Pleuritic Pain, Cardiac Arrest, Infarction
on Feb 03, 2012 Male from DENMARK , 72 years of age, was treated with Lonarid (solpadeine) (solpadeine). Directly after, patient experienced the unwanted or unexpected Lonarid side effects: condition aggravated, infection, chronic obstructive pulmonary disease, pleuritic pain, cardiac arrest, infarction. Lonarid (solpadeine) (solpadeine) dosage: N/A.
Associated medications used:
  • Roflumilast (roflumilast) (tablets) (1 Dosage Forms (1 Dosage Forms, 1 In 1 D), Oral)
  • Spiriva (tiotropium Bromide) (inhalant) (tiotropium Bromide)
  • Seretide Diskus (seretide) (inhalant) (seretide)
  • Depon (paracetamol) (paracetamol)


Thrombocytopenia, Incision Site Haemorrhage
Patient was taking Lonarid. Patient felt the following Lonarid side effects: thrombocytopenia, incision site haemorrhage on Oct 21, 2011 from GREECE Additional patient health information: Female , 74 years of age, . Lonarid dosage: N/A.
Multiple prescriptions taken:
  • Zantac
  • Blood And Related Products
  • Rivaroxaban
  • Cefuroxime Sodium
Patient was hospitalized.

Stevens-johnson Syndrome, Toxic Epidermal Necrolysis
Adverse event was reported on Jul 04, 2011 by a Female taking Lonarid-n (solpadeine /00154101/) (Dosage: N/A) . Location: GREECE , 37 years of age, weighting 176.4 lb, After Lonarid was administered, patient encountered several Lonarid side effects: stevens-johnson syndrome, toxic epidermal necrolysis.
Multiple concurrent drugs taken:
  • Methylprednisolone (medrol) (methylprednisolone)
  • Omeprazole
  • Phenytoin Sodium Cap (300 Mg, D, Oral)
  • Omniscan (Single Dose, Intravenous)


Amnesia, Body Temperature Decreased, Diarrhoea, Miosis, Post Procedural Vomiting, Suicide Attempt, Tachycardia
on Apr 07, 2006 Male from GERMANY , 28 years of age, weighting 176.4 lb, was treated with Lonarid. Directly after, patient experienced the unwanted or unexpected Lonarid side effects: amnesia, body temperature decreased, diarrhoea, miosis, post procedural vomiting, suicide attempt, tachycardia. Lonarid dosage: 20 Anz Po.
Associated medications used:
  • Optalidon (ibuprofen) (30 Anz (nr), Po)
  • Mefenamic Acid (70 Anz (500 Mg), Po)
  • Zopiclon (zopiclone) (150 Mg (7.5 Mg) Po)
Patient was hospitalized.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Lonarid Side Effects

    Did You Have a Lonarid Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Lonarid for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    More About Lonarid

    Side Effects reported to FDA: 4

    Lonarid safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 2

    Latest Lonarid clinical trials

    Lonarid Reviews

    No reviews, be a first to report a side effect via side effect reporting form